Therapie des differenzierten Schilddrüsenkarzinoms

Schlüsselwörter

Schilddrüsenkarzinom - Radiojodtherapie - Thyreoidektomie - Zytostatika - Proteinkinaseinhibitoren - Leitlinien

Keywords

thyroid neoplasm - iodine radioisotopes - thyroidectomy - antineoplastic agents - protein kinase inhibitors - guidelines for practice

Literatur

• 1 TNM Classification of Malignant Tumours, 6th edition. New York: Wiley-Liss; 2002
• 2 WHO histological classification of thyroid and parathyroid tumours. In: Delmas P, Locati LD, Heracek J, Eng C, editors World Health Organization Classification of Tumours. Pathology & Genetics. Tumours of Endocrine Organs. Lyon: IARC Press; 2004: 29-123
• 3 Brabant G. Thyrotropin suppressive therapy in thyroid carcinoma: what are the targets?.  J Clin Endocrinol Metab. 2008;  93 1167-1169
• 4 Cooper D S, Doherty G M, Haugen B R. et al . Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.  Thyroid. 2009;  19 1167-1214
• 5 Dralle H, Karges W, Reiners C, Schmid K W. Maligne Schilddrüsentumoren. In: Lehnert H, Rationelle Diagnostik und Therapie in Endokrinologie, Diabetologie und Stoffwechsel. Stuttgart, New York: Georg Thieme Verlag; 2009: 95-112
• 6 Dralle H, Lorenz K, Machens A, Nguyen T P. [Thyroid carcinoma found incidentally after thyroidectomy: postoperative strategy.  Dtsch Med Wochenschr. 2009;  134 2517-2520
• 7 Dralle H, Machens A. Surgical approaches in thyroid cancer and lymph-node metastases.  Best Pract Res Clin Endocrinol Metab. 2008;  22 971-987
• 8 Ford D, Giridharan S, McConkey C. et al . External beam radiotherapy in the management of differentiated thyroid cancer.  Clin Oncol (R Coll Radiol ). 2003;  15 337-341
• 9 Frates M C, Benson C B, Charboneau J W. et al . Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement.  Radiology. 2005;  237 794-800
• 10 Gottlieb J A, Hill Jr C S. Chemotherapy of thyroid cancer with adriamycin. Experience with 30 patients.  N Engl J Med. 1974;  290 193-197
• 11 Hackshaw A, Harmer C, Mallick U, Haq M, Franklyn J A. 131I activity for remnant ablation in patients with differentiated thyroid cancer: A systematic review.  J Clin Endocrinol Metab. 2007;  92 28-38
• 12 Harach H R, Franssila K O, Wasenius V M. Occult papillary carcinoma of the thyroid. A „normal” finding in Finland. A systematic autopsy study.  Cancer. 1985;  56 531-538
• 13 Husmann G, Kaatsch P, Katalinic A. et al .Beiträge zur Gesundheitsberichterstattung des Bundes Krebs in Deutschland 2005/2006 – Häufigkeiten und Trends. 7. Ausgabe ed. Berlin: Robert Koch-Institut, Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V.; 2010
• 14 Jonklaas J, Sarlis N J, Litofsky D. et al . Outcomes of patients with differentiated thyroid carcinoma following initial therapy.  Thyroid. 2006;  16 1229-1242
• 15 Kloos R T, Ringel M D, Knopp M V. et al . Phase II trial of sorafenib in metastatic thyroid cancer.  J Clin Oncol. 2009;  27 1675-1684
• 16 Luster M, Clarke S E, Dietlein M. et al . Guidelines for radioiodine therapy of differentiated thyroid cancer.  Eur J Nucl Med Mol Imaging. 2008;  35 1941-1959
• 17 Maenpaa H O, Heikkonen J, Vaalavirta L, Tenhunen M, Joensuu H. Low vs. high radioiodine activity to ablate the thyroid after thyroidectomy for cancer: a randomized study.  PLoS One. 2008;  3 e1885
• 18 McGriff N J, Csako G, Gourgiotis L, Lori C G, Pucino F, Sarlis N J. Effects of thyroid hormone suppression therapy on adverse clinical outcomes in thyroid cancer.  Ann Med. 2002;  34 554-564
• 19 Nikiforov Y E, Steward D L, Robinson-Smith T M. et al . Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules.  J Clin Endocrinol Metab. 2009;  94 2092-2098
• 20 Pacini F, Schlumberger M, Dralle H, Elisei R, Smit J W, Wiersinga W. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium.  Eur J Endocrinol. 2006;  154 787-803
• 21 Pacini F, Ladenson P W, Schlumberger M, Driedger A, Luster M, Kloos R T. et al . Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study.  J Clin Endocrinol Metab. 2006;  91 926-932
• 22 Schmid K W. Knoten in der Schilddrüse – histologische und zytologische Diagnostik.  Nuklearmediziner. 2008;  31 203-208
• 23 Thomusch O, Sekulla C, Walls G, Fasshauer M, Dralle H. Analysis of surgery-related complications in thyroid carcinoma – a German prospective multi-centre study with 275 patients.  Acta Chirurgica Austriaca. 2001;  33 194-198